What is ribavirin?
Ribavirin is anprescription medicine approved by the U.S. (FDA) for the treatment of chronic (HCV). Ribavirin is always used in combination with other drugs.
HCV What is an Opportunistic Infection? fact sheet.can be an (OI) of HIV. An OI is an infection that occurs more frequently or is more severe in people with weakened immune systems—such as people with HIV—than in people with healthy immune systems. To learn more about OIs, read the HIVinfo
To learn how HIV and HCV are connected, read the HIVinfo HIV and Hepatitis C fact sheet. The fact sheet includes information about how HCV is spread, symptoms of HCV, and treatment options.
How is ribavirin used in people with HIV?
The Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV reference the AASLD-IDSA HCV Guidance: Recommendations for Testing, Managing, and Treating C, which includes recommendations on the use of ribavirin to treat acute and chronic HCV infection in people with HIV.The recommended uses may not always be consistent with FDA-approved uses of ribavirin. See the Guidelines for complete information on recommended uses of ribavirin in adults and adolescents with HIV. Some recommended uses, such as uses in certain rare circumstances, may have been omitted above.
What should I tell my health care provider before taking ribavirin?
Before taking ribavirin, tell your health care provider:
- If you are allergic to ribavirin or any other medicines.
- About any medical conditions you have or have had, including:
- Breathing or vision problems
- Blood disorders, such as
- , high blood pressure, heart problems, or heart attack
- Thyroid, kidney or problems, including (HBV)
- Mental health problems, including and thoughts of hurting yourself or others
- Organ transplant
- Drug addiction or abuse
- If you have ever had treatment for hepatitis C virus infection that did not work for you.
- About anything that could affect your ability to take medicines, such as difficulty swallowing or remembering to take pills.
- If you are pregnant or plan to become pregnant. Ribavirin should not be used during pregnancy. Talk to your health care provider about the risks of taking ribavirin during pregnancy.
- If you are breastfeeding or plan to breastfeed. For women with HIV in the United States, the Guideline does not recommend breastfeeding. Before your baby is born, or if you are already breastfeeding, talk to your health care provider to discuss alternative options for feeding your baby.
- About other prescription and nonprescription medicines, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Ribavirin may affect the way other medicines or products work, and other medicines or products may affect how ribavirin works. Ask your health care provider if there are interactions between ribavirin and the other medicines you take.
Ask your health care provider about possible side effects from ribavirin. Your health care provider will tell you what to do if you have side effects.
How should I take ribavirin?
Take ribavirin according to your health care provider’s instructions. Your health care provider will tell you how much ribavirin to take and when to take it. Before you start ribavirin and each time you get a refill, read any printed information that comes with your medicine.
How should ribavirin be stored?
- Store ribavirin tablets and capsules at room temperature, between 68°F and 77°F (20°C to 25°C).
- Store ribavirin oral solution at room temperature, between 68°F and 77°F (20°C to 25°C), or in the refrigerator, between 36°F and 46°F (2°C to 8°C).
- Keep ribavirin in the container that it came in and keep the container tightly closed.
- Do not use ribavirin if the original seal over the medicine container opening is broken or missing.
- Throw away ribavirin that is no longer needed or expired (out of date). Follow FDA guidelines on how to safely dispose of unused medicine.
- Keep ribavirin and all medicines out of reach of children.
Where can I find more information about ribavirin?
- Recommendations on the HIV-related uses of ribavirin, from the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV, prepared by the , the , and the HIV Medicine Association of the Diseases Society of America
- Recommendations on the HIV-related uses of ribavirin, from the AASLD-IDSA HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C, prepared by the American Association for the Study of Diseases and the Infectious Diseases Society of America
- This Patient Version drug summary is based on the following FDA label(s): Capsule, liquid; Tablet (film coated). The Patient Counseling Information section of the label includes information for people taking ribavirin.
- Ribavirin-related research studies, from
Last Reviewed: January 8, 2021